These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24844043)
1. Combating the prescription painkiller epidemic: a national prescription drug reporting program. Shepherd J Am J Law Med; 2014; 40(1):85-112. PubMed ID: 24844043 [TBL] [Abstract][Full Text] [Related]
2. The US Opioid Crisis: Current Federal and State Legal Issues. Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113 [TBL] [Abstract][Full Text] [Related]
4. An opioid dispensing and misuse prevention algorithm for community pharmacy practice. Rickles NM; Huang AL; Gunther MB; Chan WJ Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483 [TBL] [Abstract][Full Text] [Related]
5. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. Garcia AM J Law Med Ethics; 2013 Mar; 41 Suppl 1():42-5. PubMed ID: 23590739 [TBL] [Abstract][Full Text] [Related]
7. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use. Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394 [TBL] [Abstract][Full Text] [Related]
8. Prescription drug monitoring programs: examining limitations and future approaches. Griggs CA; Weiner SG; Feldman JA West J Emerg Med; 2015 Jan; 16(1):67-70. PubMed ID: 25671011 [TBL] [Abstract][Full Text] [Related]
9. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed? Peckham AM; Fairman KA; Sclar DA Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090 [TBL] [Abstract][Full Text] [Related]
10. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients. Riley TB; Alemagno S Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825 [TBL] [Abstract][Full Text] [Related]
11. Corneal abrasions and controlled substances. Brockman TA J Okla State Med Assoc; 2014 Jul; 107(7):374-5. PubMed ID: 25223150 [No Abstract] [Full Text] [Related]
12. Benefits and Limits of Abuse-Deterrent Painkillers. Hendrikson H; Hanson K NCSL Legisbrief; 2016 Feb; 24(6):1-2. PubMed ID: 27032127 [TBL] [Abstract][Full Text] [Related]
13. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. Cobaugh DJ; Gainor C; Gaston CL; Kwong TC; Magnani B; McPherson ML; Painter JT; Krenzelok EP Am J Health Syst Pharm; 2014 Sep; 71(18):1539-54. PubMed ID: 25174015 [TBL] [Abstract][Full Text] [Related]
14. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group. Young LD; Kreiner PW; Panas L Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713 [TBL] [Abstract][Full Text] [Related]
15. Systematic Literature Review of Prescription Drug Monitoring Programs. Ponnapalli A; Grando A; Murcko A; Wertheim P AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193 [TBL] [Abstract][Full Text] [Related]
17. Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse. Norwood CW; Wright ER Res Social Adm Pharm; 2016; 12(3):509-14. PubMed ID: 26329535 [TBL] [Abstract][Full Text] [Related]
18. Regulating gabapentin as a drug of abuse: A survey study of Kentucky community pharmacists. Blackmer J; Lindahl E; Strahl A; Schadler A; Freeman PR J Am Pharm Assoc (2003); 2019; 59(3):379-382. PubMed ID: 30786971 [TBL] [Abstract][Full Text] [Related]
20. A prescription drug monitoring program, data sharing, and upholding states' rights under the United States Constitution. Pehrson A; Solla CA; Buehler J; Vance M J Public Health Policy; 2023 Mar; 44(1):102-109. PubMed ID: 36624270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]